From the Food and Drug Administration. Interferon alfa approved for Kaposi's sarcoma
Nightingale, S.L.
JAMA 261(3): 350
1989
ISSN/ISBN: 0098-7484 PMID: 2909766 Document Number: 328618
Document emailed within 1 workday
Related Documents
McNicholas, C.; Maddipati, R.; Zhao, Q.; Swor, E.; Peipert, J.F. 2015: Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. Food and Drug Administration-approved duration Obstetrics and Gynecology 125(3): 599-604Gao, R. 2014: Firehawk® sirolimus target-eluting coronary stent approved by China Food and Drug Administration European Heart Journal 35(38): 2623-2624
Fernández, I.; Castellano, G.; Canga, F.; Colina, F.; García, H.; Fuertes, A.; Casis, B.; Martín, A.; Solís, J.A. 1995: A comparative randomized controlled study of the efficacy of interferon alfa-2b and interferon alfa-2a in the treatment of chronic hepatitis C Gastroenterologia y Hepatologia 18(2): 66-72
Abrams, D.I.; Volberding, P.A. 1987: Alpha interferon therapy of AIDS-associated Kaposi's sarcoma Seminars in Oncology 14(2 Suppl 2: 43-47
Krown, S.E. 1987: The role of interferon in the therapy of epidemic Kaposi's sarcoma Seminars in Oncology 14(2 Suppl 3: 27-33
Warmuth, I.; Moore, P.S. 1997: Kaposi sarcoma, Kaposi sarcoma-associated herpesvirus, and human T-cell lymphotropic virus type 1. what is the current evidence for causality? Archives of Dermatology 133(1): 83-85
Olsen, S.J.; Chang, Y.; Moore, P.S.; Biggar, R.J.; Melbye, M. 1998: Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985 Aids 12(14): 1921-1925
Ghyka, G.; Alecu, M.; Hălălău, F.; Călugăru, A.; Coman, G. 1991: Human leukocyte interferon treatment associated with IL-2 in the non-AIDS related Kaposi's sarcoma Romanian Journal of Internal Medicine 29(1-2): 75-83
Fischl, M.A.; Uttamchandani, R.B.; Resnick, L.; Agarwal, R.; Fletcher, M.A.; Patrone-Reese, J.; Dearmas, L.; Chidekel, J.; McCann, M.; Myers, M. 1991: A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma Journal of Acquired Immune Deficiency Syndromes 4(1): 1-10
Alecu, M.; Ghyka, G.; Hălălău, F.; Călugăru, A.; Coman, G. 1990: Intralesional human leukocyte interferon treatment in the non-AIDS related Kaposi's sarcoma Medecine Interne 28(1): 61-67
Borleffs, J.C.; Hoepelman, I.M.; van der Ende, M.E.; van Leusen, R.; van 't Wout, J.W. 1991: Triple therapy with vinblastine, interferon-alpha 2a and zidovudine for AIDS-related Kaposi's sarcoma Journal of Acquired Immune Deficiency Syndromes 4(11): 1161-1162
Mitsuyasu, R.T. 1989: The enhanced potential use of recombinant alpha interferon in the treatment of AIDS-related Kaposi's sarcoma Oncology Nursing Forum 16(6): 5-7
Plettenberg, A.; Albrecht, D.; Lorenzen, T.; Meyer, T.; Arndt, R.; Stoehr, A. 2002: Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma European Journal of Medical Research 7(1): 19-24
Stadler, R.; Bratzke, B.; Orfanos, C.E. 1987: Therapeutic use of alpha interferon in metastasizing malignant melanoma, disseminated Kaposi sarcoma and severe Behçet disease Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 38(8): 453-460
Simonart, T.; Dobbeleer, G.D.; Peny, M.; Fayt, I.; Parent, D.; Vooren, J.; Noel, J. 1999: Pre-Kaposi's sarcoma: an expansion of the spectrum of Kaposi's sarcoma lesions European Journal of Dermatology: Ejd 9(6): 480-482
Ambrus, J.L.; Poiesz, B.J.; Lillie, M.A.; Stadler, I.; Di Berardino, L.A.; Chadha, K.C. 1989: Interferon and interferon inhibitor levels in patients infected with varicella-zoster virus, acquired immunodeficiency syndrome, acquired immunodeficiency syndrome-related complex, or Kaposi's sarcoma, and in normal individuals American Journal of Medicine 87(4): 405-407
Căluşer, I.; Mocanu, G.; Olinici, C.D.; Iconomou, D.; Spanudakis, S. 1985: Drug-induced immunodeficiency associated with nodal Kaposi's sarcoma Morphologie et Embryologie 31(4): 279-281
Krown, S.E.; Gold, J.W.; Niedzwiecki, D.; Bundow, D.; Flomenberg, N.; Gansbacher, B.; Brew, B.J. 1990: Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS) Annals of Internal Medicine 112(11): 812-821
Huang, K.-M.; Hsu, C.-H.; Cheng, J.C.-H.; Lai, M.-K.; Jeng, S.-C.; Ting, L.-L.; Huang, W.-T. 2006: Radiotherapy of classic Kaposi's sarcoma in Taiwan, an area where classic Kaposi's sarcoma is not prevalent Anticancer Research 26(6c): 4659-4663
Reinfuss, M. 1987: Kaposi's sarcoma. Clinical picture, treatment and prognosis. I. Clinical forms of Kaposi's sarcoma Nowotwory 37(3): 195-206